3ŒŽ27“ú(æ—¥)@9:00~11:00@F‰ïê パシフィコ横浜 会è°ã‚»ãƒ³ã‚¿ãƒ¼ã€€3F 311+312 GS01 次世代型創薬ã®å¯èƒ½æ€§ã‚’探る ―既承èªè–¬ãƒ»é–‹ç™ºä¸æ¢å“ã®å¿œç”¨ã‚’指å‘ã—ãŸç ”究― Seeking the Prospects for Next-Generation Drug Discovery—Toward New Uses of Existing Drugs for New Indications— オーガナイザー:鈴木 ä¿Šç« ã€æ²¢å´Ž 綾一 GS01-1 既承èªè–¬ãƒ©ã‚¤ãƒ–ラリーを用ã„ãŸæ–°è¦ãƒ‰ãƒ©ã‚¤ã‚¢ã‚¤æ²»ç™‚è–¬ã®æŽ¢ç´¢ Search of the new therapeutic drug for dry eye syndrome using the approved medicines library ƒVƒ“ƒ|ƒWƒXƒg F ○沢崎 綾一ã€çŸ³åŽŸ 知明ã€æ°´å³¶ å¾¹ GS01-2 フルオãƒã‚ノãƒãƒ³ç³»æŠ—èŒè–¬ã«ã‚ˆã‚‹ç¶²è†œç´°èƒžä¿è·ä½œç”¨ Protective effect of fluoroquinolones in cultured retinal cell line ƒVƒ“ƒ|ƒWƒXƒg F ○久世 祥己ã€è¥¿ç”° å´‡ã€æœ›æœˆ 清文ã€å¶‹æ¾¤ é›…å…‰ã€å±±æœ¬ 哲也ã€åŽŸ 英彰 GS01-3 メラノーマ治療薬ã¨ã—ã¦é–‹ç™ºã•ã‚ŒãŸMEK阻害剤ã®å¤§è…¸ãŒã‚“治療薬ã¨ã—ã¦ã®å¯èƒ½æ€§ Drug repositioning of MEK inhibitor, originally developed for melanoma, to the agent for colon cancer ƒVƒ“ƒ|ƒWƒXƒg F ○四方 雄貴ã€æœ¨æˆ‘ 真基ã€ç”°ä»£ 悦ã€äº•æœ¬ æ£å“‰ GS01-4 æ—¢å˜åŒ»è–¬å“を用ã„ãŸãƒˆãƒªãƒ—ルãƒã‚¬ãƒ†ã‚£ãƒ–ä¹³ãŒã‚“ã®æ–°è¦æ²»ç™‚戦略 New Therapeutic Strategy and Drug Repositioning for Triple Negative Breast Cancer ƒVƒ“ƒ|ƒWƒXƒg F â—‹æ¾äº• åƒç´˜ã€ä¸ç€¬ 朋å¤ã€å·åŽŸ ã•ã¨å®Ÿã€é«™æ©‹ 幸一 GS01-5 ゾレドãƒãƒ³é…¸ã¨ãƒ•ãƒ«ãƒã‚¹ã‚¿ãƒãƒ³ã®ä½µç”¨ã«ã‚ˆã‚‹ãƒ’ト膵臓ãŒã‚“細胞増殖抑制ã®å¢—強効果 Synergistic antiproliferation effect on human pancreatic cancer by combination of zoledronic acid and fluvastatin ƒVƒ“ƒ|ƒWƒXƒg F ○岡 雄平ã€å°æž— 大介ã€çªªç”° æ•å¤«ã€EL-SAYED Mahitabã€å³¶æ·» 隆雄 GS01-6 Bile salt export pump (BSEP)/ABCB11ã®éºä¼å変異ã«èµ·å› ã™ã‚‹é›£æ²»æ€§å°å…è‚内胆æ±ã†ã£æ»žç—‡ã«å¯¾ã™ã‚‹æ²»ç™‚è–¬ã®é–‹ç™º Development of new drug for familial intrahepatic cholestasis ƒVƒ“ƒ|ƒWƒXƒg F ○廣瀬 å‹ã€æž— ä¹…å…ã€æ¥ 原 洋之 GS01-7 消化管GVHD治療薬ã¨ã—ã¦ã®çµŒå£ãƒ™ã‚¯ãƒãƒ¡ã‚¿ã‚¾ãƒ³è£½å‰¤ Oral beclomethazone dipropionate for the treatment of gastroinestinal GVHD ƒVƒ“ƒ|ƒWƒXƒg F ○三谷 å¥äººã€å²¸ä¸Š ã•ã‚„ã‹ã€å¾Œè—¤ 梓沙ã€æž— 寛åã€å…¼æ‘ ä¿¡å®ã€æ›½ç”° ç¿ ã€éˆ´æœ¨ æ˜å¤«ã€ç¬ 原 åƒå—£ã€é¶´è¦‹ 寿ã€ä¼Šè—¤ å–„è¦ã€åŒ—市 清幸 GS01-8 Potential restoration of memory impairment in dementia by the Kampo formulation, nobiletin-rich chinpi-containing yokukansankachinpihange Potential restoration of memory impairment in dementia by the Kampo formulation, nobiletin-rich chinpi-containing yokukansankachinpihange ƒVƒ“ƒ|ƒWƒXƒg F â—‹GUTIERREZ RICO Evelynã€å¾ 寧ã€å·ç•‘ 伊知郎ã€å®‰è—¤ 英広ã€å‰ç”° é›…æ˜ã€å±±åœ‹ å¾¹ GS01-9 Oxaliplatinã«ã‚ˆã‚‹æœ«æ¢¢ç¥žçµŒéšœå®³æ€§ç–¼ç—›ã«å¯¾ã™ã‚‹äººå‚é¤Šæ „æ¹¯ã®æœ‰åŠ¹æ€§ã®æ¤œè¨Ž Relieving effect of ninjin’yoeito on oxaliplatin-induced neuropathic pain ƒVƒ“ƒ|ƒWƒXƒg F ○鈴木 ä¿Šç« ã€å±±æœ¬ 彩乃ã€å¤§æ¾¤ 匡弘ã€å…ƒé›„ 良治ã€æ°´ä¸Š å…ƒã€ç‰§é‡Ž 利明 ŒŸõƒy[ƒW‚É–ß‚é